Biovest to make presentation on BiovaxID cancer vaccine at World Vaccine Congress 2010

Biovest International, Inc. (Other OTC:BVTI) today announced that the Company will be making a presentation regarding its personalized cancer vaccine, BiovaxID®, on April 22 at the World Vaccine Congress which is currently ongoing in Washington D.C.

“Personalized biologic therapeutic cancer vaccine for the treatment of non-Hodgkin's lymphoma”

Biovest's Vice President, Product Development & Regulatory Affairs, Dr. Carlos Santos, will deliver a presentation titled, "Personalized biologic therapeutic cancer vaccine for the treatment of non-Hodgkin's lymphoma" as part of the Cancer Immunotherapies track of the conference. Other companies presenting as part of the Cancer Immunotherapies track include Dendreon, BioVex, GlaxoSmithKline and Vaccinogen.

Event: World Vaccine Congress 2010

Place: Westfields Marriott Washington Dulles

Biovest Presentation Day/Time: Thursday, April 22^nd at 11:15 a.m.